cea4063-sup-0001-FigureS1.tifimage/tif59097KFigure S1. TSO treatment does not alter cytokine production by PBMCs in response to PMA/ionomycin re-stimulation.
cea4063-sup-0002-FigureS2.tifimage/tif64411KFigure S2. TSO treatment does not alter birch pollen-specific PBMC cytokine levels.
cea4063-sup-0003-TableS1.docWord document63KTable S1. Serological characteristics of the T. suis- and placebo-treated participants differ after but not before initial treatment
cea4063-sup-0004-TableS2.docWord document51KTable S2. The number of TSO treatments received prior to the grass pollen season did not influence plasma cytokine responses during the grass pollen season.
cea4063-sup-0005-TableS3.docWord document49KTable S3. The total number of TSO treatments did not influence plasma cytokine responses at the end of the study.
cea4063-sup-0006-TableS4.docxWord document17KTable S4. TSO treatment does not affect levels of PBMC cytokines in PBMCs cultured without antigens and re-stimulated with PMA/ionomycin.

Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.